431 related articles for article (PubMed ID: 35185901)
1. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosis.
Ding D; Luan R; Xue Q; Yang J
Cytokine; 2023 Dec; 172():156387. PubMed ID: 37826869
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
4. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
[TBL] [Abstract][Full Text] [Related]
5. mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis.
Paplińska-Goryca M; Goryca K; Misiukiewicz-Stępień P; Nejman-Gryz P; Proboszcz M; Górska K; Maskey-Warzęchowska M; Krenke R
Eur J Clin Invest; 2019 Sep; 49(9):e13153. PubMed ID: 31246273
[TBL] [Abstract][Full Text] [Related]
6. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
[TBL] [Abstract][Full Text] [Related]
7. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
8. CD247, a Potential T Cell-Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; Chen S; Li X; Wang X; Li H; Ning S; Chen H
Front Immunol; 2021; 12():762594. PubMed ID: 34880861
[TBL] [Abstract][Full Text] [Related]
9. An 8-ferroptosis-related genes signature from Bronchoalveolar Lavage Fluid for prognosis in patients with idiopathic pulmonary fibrosis.
He Y; Shang Y; Li Y; Wang M; Yu D; Yang Y; Ning S; Chen H
BMC Pulm Med; 2022 Jan; 22(1):15. PubMed ID: 34983465
[TBL] [Abstract][Full Text] [Related]
10. S100 Calcium-Binding Protein A9, a Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis.
Lee JU; Kim MK; Kim MS; Lee SJ; Park SL; Chang HS; Park JS; Park CS
J Korean Med Sci; 2024 Jan; 39(1):e13. PubMed ID: 38193329
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
[TBL] [Abstract][Full Text] [Related]
12. Expression of S100A9 and KL-6 in common interstitial lung diseases.
Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q
Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
14. Identification of Pro-Fibrotic Macrophage Populations by Single-Cell Transcriptomic Analysis in West Highland White Terriers Affected With Canine Idiopathic Pulmonary Fibrosis.
Fastrès A; Pirottin D; Fievez L; Tutunaru AC; Bolen G; Merveille AC; Marichal T; Desmet CJ; Bureau F; Clercx C
Front Immunol; 2020; 11():611749. PubMed ID: 33384697
[TBL] [Abstract][Full Text] [Related]
15. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a bronchoalveolar lavage cell-associated gene signature for prognosis prediction in idiopathic pulmonary fibrosis.
Xia Y; Lei C; Yang D; Luo H
Int Immunopharmacol; 2021 Mar; 92():107369. PubMed ID: 33493738
[TBL] [Abstract][Full Text] [Related]
17. The Combined Model of CX3CR1-Related Immune Infiltration Genes to Evaluate the Prognosis of Idiopathic Pulmonary Fibrosis.
Cai H; Chen S; Li X; Liu H; Zhang Y; Zhuang Q
Front Immunol; 2022; 13():837188. PubMed ID: 35222428
[TBL] [Abstract][Full Text] [Related]
18. Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis.
Li X; Cai H; Cai Y; Zhang Q; Ding Y; Zhuang Q
Front Immunol; 2021; 12():629854. PubMed ID: 34194423
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
